{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:59:51Z","timestamp":1776135591821,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National key research and development program of China","doi-asserted-by":"publisher","award":["SQ2017YFSF090096"],"award-info":[{"award-number":["SQ2017YFSF090096"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Prostate Cancer Foundation Young Investigator Award 2013"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300627"],"award-info":[{"award-number":["81300627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370855"],"award-info":[{"award-number":["81370855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702536"],"award-info":[{"award-number":["81702536"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770756"],"award-info":[{"award-number":["81770756"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programs from Science and Technology Department of Sichuan Province","award":["2018JY0089"],"award-info":[{"award-number":["2018JY0089"]}]},{"name":"Programs from Science and Technology Department of Sichuan Province","award":["2017HH0063"],"award-info":[{"award-number":["2017HH0063"]}]},{"name":"Young Investigator Award of Sichuan University 2017","award":["2017SCU04A17"],"award-info":[{"award-number":["2017SCU04A17"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.cca.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T11:06:34Z","timestamp":1549883194000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Predictive value of preoperative lymphocyte-to-monocyte ratio for patients with upper tract urothelial carcinoma"],"prefix":"10.1016","volume":"492","author":[{"given":"Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-3042","authenticated-orcid":false,"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cca.2019.02.007_bb0005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.cca.2019.02.007_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10147-017-1184-0","article-title":"Significance of multiple preoperative laboratory abnormalities as prognostic indicators in patients with urothelial carcinoma of the upper urinary tract following radical nephroureterectomy","volume":"23","author":"Nishikawa","year":"2018","journal-title":"Int. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.cca.2019.02.007_bb0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/jclinpath-2014-202658","article-title":"Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma","volume":"68","author":"Hutterer","year":"2015","journal-title":"J. Clin. Pathol."},{"issue":"8","key":"10.1016\/j.cca.2019.02.007_bb0020","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s11255-017-1613-z","article-title":"The De Ritis (aspartate transaminase\/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma","volume":"49","author":"Cho","year":"2017","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cca.2019.02.007_bb0025","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/1471-2407-14-462","article-title":"Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival","volume":"14","author":"Kiba","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cca.2019.02.007_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update","volume":"73","author":"Roupret","year":"2018","journal-title":"Eur. Urol."},{"issue":"13","key":"10.1016\/j.cca.2019.02.007_bb0035","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.25050","article-title":"Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma","volume":"116","author":"Matin","year":"2010","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.cca.2019.02.007_bb0040","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/jjco\/hyw129","article-title":"A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy","volume":"45","author":"Yoshida","year":"2015","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2019.02.007_bb0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.juro.2015.01.083","article-title":"The preoperative AST\/ALT (De Ritis) ratio represents a poor prognostic factor in a cohort of patients with nonmetastatic renal cell carcinoma","volume":"194","author":"Bezan","year":"2015","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.cca.2019.02.007_bb0050","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/j.clgc.2016.08.023","article-title":"De Ritis ratio (AST\/ALT) as a significant prognostic factor in patients with upper tract urothelial cancer treated with surgery","volume":"15","author":"Lee","year":"2017","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.cca.2019.02.007_bb0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cca.2018.06.019","article-title":"The prognostic value of preoperative neutrophil-to-lymphocyte ratio in patients with upper tract urothelial carcinoma","volume":"485","author":"Tan","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.cca.2019.02.007_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000477405","article-title":"Integrative assessment of pretreatment inflammation-, nutrition-, and muscle-based prognostic markers in patients with muscle-invasive bladder cancer undergoing radical cystectomy","volume":"93","author":"Miyake","year":"2017","journal-title":"Oncology"},{"issue":"4","key":"10.1016\/j.cca.2019.02.007_bb0065","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.juro.2013.10.073","article-title":"Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma","volume":"191","author":"Pichler","year":"2014","journal-title":"J. Urol."},{"issue":"10","key":"10.1016\/j.cca.2019.02.007_bb0070","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/bjc.2014.180","article-title":"Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma","volume":"110","author":"Dalpiaz","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.cca.2019.02.007_bb0075","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1007\/s13277-015-3613-x","article-title":"Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour Biol."},{"issue":"11","key":"10.1016\/j.cca.2019.02.007_bb0080","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4111\/kju.2015.56.11.749","article-title":"Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma","volume":"56","author":"Lee","year":"2015","journal-title":"Korean J. Urol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.007_bb0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/bjc.2013.785","article-title":"The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer","volume":"110","author":"Stotz","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.cca.2019.02.007_bb0090","doi-asserted-by":"crossref","first-page":"737","DOI":"10.7150\/jca.17668","article-title":"Peripheral blood lymphocyte-to-monocyte ratio as a prognostic factor in advanced epithelial ovarian cancer: a multicenter retrospective study","volume":"8","author":"Zhu","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.cca.2019.02.007_bb0095","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Werb","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cca.2019.02.007_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2490-14-76","article-title":"Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis","volume":"14","author":"Temraz","year":"2014","journal-title":"BMC Urol."},{"issue":"6","key":"10.1016\/j.cca.2019.02.007_bb0105","first-page":"348","article-title":"Preoperative low lymphocyte-to-monocyte ratio predicts poor clinical outcomes for patients with urothelial carcinoma of the upper urinary tract","volume":"15","author":"Zhang","year":"2018","journal-title":"Urol. J."},{"issue":"6835","key":"10.1016\/j.cca.2019.02.007_bb0110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/35077246","article-title":"Progress in human tumour immunology and immunotherapy","volume":"411","author":"Rosenberg","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cca.2019.02.007_bb0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0090-4295(98)00447-6","article-title":"Analysis of the peripheral blood lymphocyte subsets in patients with bladder carcinoma","volume":"53","author":"Soygur","year":"1999","journal-title":"Urology"},{"issue":"6d","key":"10.1016\/j.cca.2019.02.007_bb0120","first-page":"5185","article-title":"Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma","volume":"23","author":"Kastelan","year":"2003","journal-title":"Anticancer Res."},{"issue":"8","key":"10.1016\/j.cca.2019.02.007_bb0125","first-page":"2553","article-title":"Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance","volume":"8","author":"Hoffmann","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.cca.2019.02.007_bb0130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/ijc.26123","article-title":"Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer","volume":"130","author":"Eruslanov","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.cca.2019.02.007_bb0135","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cca.2019.02.007_bb0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","article-title":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis","volume":"124","author":"Condeelis","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cca.2019.02.007_bb0145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.1027","article-title":"The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies","volume":"196","author":"Bingle","year":"2002","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.cca.2019.02.007_bb0150","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pan.2013.06.010","article-title":"Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer","volume":"13","author":"Partecke","year":"2013","journal-title":"Pancreatology"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119300592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119300592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T15:41:26Z","timestamp":1565192486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119300592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":30,"alternative-id":["S0009898119300592"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.02.007","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of preoperative lymphocyte-to-monocyte ratio for patients with upper tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}